Indiana Medicaid spending on GLP-1 drugs

How much did Indiana Medicaid spend on GLP-1 drugs like Ozempic and Mounjaro in 2025?

Pharmacies were reimbursed at least $204.8 million for GLP-1 drugs paid through Indiana Medicaid in 2025, across at least 190,162 prescriptions, according to CMS’s State Drug Utilization Data. That is the total amount reimbursed, federal and state shares together, before the rebates manufacturers pay states. CMS suppressed 82 rows of 297, so these figures are floors.

Pharmacies were reimbursed at least $46.4 million for GLP-1 drugs paid through Indiana Medicaid in 2026 (quarter 1 only, as posted so far), across at least 41,444 prescriptions, according to CMS’s State Drug Utilization Data. That is the total amount reimbursed, federal and state shares together, before the rebates manufacturers pay states. CMS suppressed 19 rows of 82, so these figures are floors.

By year and ingredient

2020at least $20,254,059No dataat least $20,302,665at least $13,204,457at least $4,143,465Suppressedat least $225,150at least $90,258at least $58,220,054
2021at least $40,050,400No data$20,087,410at least $27,487,519at least $3,825,421Suppressedat least $271,991at least $86,652at least $91,809,392
2022at least $67,006,099at least $3,384,724$9,763,308at least $49,200,838at least $5,885,130Suppressedat least $303,952at least $88,335at least $135,632,387
2023at least $105,945,078at least $25,133,174at least $6,630,693at least $54,610,078at least $6,290,364No dataat least $360,267at least $82,040at least $199,051,693
2024at least $143,918,036at least $28,607,460at least $2,688,895at least $34,163,106at least $935,098No dataat least $229,183Suppressedat least $210,541,778
2025at least $151,406,860at least $21,445,630at least $819,590at least $30,812,313at least $118,436No dataat least $161,175Suppressedat least $204,764,005
2026 (Q1)at least $31,603,949at least $8,185,632at least $164,365$6,432,767No dataNo dataat least $26,817No dataat least $46,413,529

By product, 2025

Ozempicat least $145,777,798at least 135,53910 of 36
Rybelsusat least $1,188,645at least 9808 of 24
Wegovyat least $4,440,417at least 3,2975 of 40
Mounjaroat least $15,825,936at least 13,7091 of 48
Zepboundat least $5,619,694at least 5,45214 of 36
Liraglutide (generic name listing)at least $492,378at least 1,30719 of 40
SaxendaSuppressedSuppressed5 of 5
Victozaat least $327,213at least 5504 of 12
Trulicityat least $30,812,313at least 29,0493 of 35
Bydureonat least $67,906at least 791 of 3
Byettaat least $50,531at least 512 of 4
Exenatide (generic name listing)SuppressedSuppressed3 of 3
Soliquaat least $161,175at least 1494 of 8
XultophySuppressedSuppressed3 of 3

By quarter, 2025

Q1 2025at least $52,838,081at least 48,29224 of 73
Q2 2025at least $51,362,146at least 48,31523 of 74
Q3 2025at least $51,220,002at least 47,92918 of 74
Q4 2025at least $49,343,776at least 45,62617 of 76

By quarter, 2026 (posted so far)

Q1 2026at least $46,413,529at least 41,44419 of 82

The amounts are CMS’s “Total Amount Reimbursed” field. CMS’s data dictionary for State Drug Utilization Data says of it:

“This total is not reduced or affected by Medicaid rebates paid to the state. This amount represents both the Federal and State Reimbursement and is inclusive of dispensing fees.”

Its prescription count is “The number of prescriptions reimbursed (by the Medicaid Program ONLY) to pharmacists for the (11-digit NDC) drug for the period covered.”

CMS suppresses some rows (its “Suppression Used” field is true and the counts and amounts are left blank). Here a suppressed row is never counted as zero: a figure that includes suppressed rows is shown as “at least” the sum of the rows CMS did publish, and a figure where every row is suppressed is shown as “Suppressed.” The “Rows suppressed” column gives the count. Where many rows are suppressed, the published sum can be well below the full amount, so floors for different states are not directly comparable.

Fee-for-service and managed care rows are added together. Other states: Medicare and Medicaid spending on GLP-1 drugs.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.